Lauren M. Sabella, Chief Commercial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 5,859 shares at $27.84 ($163K) on 2018-06-28, disclosed to the SEC on 2018-07-02.
Scheduled sale ($163k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-21 | $210K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-06-12 | $853K | — | Filing → |